|
|
Volumn 12, Issue 1-2, 2002, Pages 149-154
|
|
Manipulation of the tumour-associated vasculature to improve tumour therapy
|
|
Author keywords
Solid tumour; Stealth liposome; Tumour necrosis factor alpha; Tumour vasculature; Vascular manipulation
|
|
Indexed keywords
CISPLATIN;
CISPLATIN DERIVATIVE;
DOXORUBICIN;
DOXORUBICIN DERIVATIVE;
LIPOSOME;
MELPHALAN;
PEGYLATED LIPOSOMAL CISPLATIN;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
BLOOD VESSEL PERMEABILITY;
BODY WEIGHT DISORDER;
CANCER IMMUNOTHERAPY;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIARRHEA;
DRUG ACCUMULATION;
DRUG DELIVERY SYSTEM;
DRUG MECHANISM;
ENDOTHELIUM CELL;
GROWTH INHIBITION;
HUMAN;
NONHUMAN;
PERFUSION;
PRIORITY JOURNAL;
RAT;
TUMOR BLOOD FLOW;
TUMOR VASCULARIZATION;
WEIGHT REDUCTION;
ANIMALS;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
NEOPLASMS, EXPERIMENTAL;
NEOVASCULARIZATION, PATHOLOGIC;
PERFUSION;
RATS;
TIME FACTORS;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0036331192
PISSN: 08982104
EISSN: None
Source Type: Journal
DOI: 10.1081/LPR-120004788 Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (14)
|
